Author/Authors :
Taheri, Ahmad Reza Cutaneous Leishmaniasis Research Center - Mashhad University of Medical Sciences, Mashhad, Iran , Afkhamizadeh, Mozhgan Metabolic Syndrome Research Center - Department of Endocrinology - Imam Reza Hospital - Mashhad University of Medical Sciences, Mashhad, Iran , Sabourirad, Sara Cutaneous Leishmaniasis Research Center - Mashhad University of Medical Sciences, Mashhad, Iran , Hassani, Omid Birjand University of Medical Sciences, Birjand, Iran , Ghanizadeh, Somaye Dermatology Department - Mashhad University of Medical Sciences, Mashhad, Iran
Abstract :
Background: Androgenetic alopecia (AGA) is the most prevailing
type of progressive hair loss. Thus far, some previous studies
have investigated the correlation between AGA and metabolic
syndrome (MetS). However, due to the inconsistency of their
results, our study aims at evaluating the association between
AGA and MetS.
Methods: Fifty two male patients with grade III-V AGA, based
on Ebling’s scale, and 50 control subjects were enrolled in the
present study. All participants were evaluated for the presence
of Mets based on the National Cholesterol Education Program
(NCEP) Adult Treatment Panel III (ATP III).
Results: The prevalence of MetS was 51.3% in AGA group and
17.8% in control group (P=0.003). Among MetS parameters, Systolic
blood pressure (P=0.003) and waist circumference (P<0.001)
were statistically significant in AGA patients compared to the
control group.
Conclusion: Our study demonstrated that the association between
AGA and MetS is of great importance. Therefore, early detection
can be beneficial for early intervention to lower the incidence of
MetS and further complications.
